Liver Transplantation Market Forecast and Segments, 2016-2026
Liver transplantation or hepatic transplantation is a surgical procedure performed when the liver fails to perform its normal functions such as synthesis of carbohydrates, proteins and fats. The liver is the second most commonly transplanted major organ, after the kidney, so it is clear that liver disease is a common and serious problem.
Liver transplantation or hepatic transplantation is a surgical procedure performed when the liver fails to perform its normal functions such as synthesis of carbohydrates, proteins and fats. The liver is the second most commonly transplanted major organ, after the kidney, so it is clear that liver disease is a common and serious problem.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Liver</strong><br />
<strong>Transplantation</strong><br />
<strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> <strong>Forecast</strong>,<br />
<strong>2016</strong>– <strong>2026</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We<br />
combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for our<br />
client.<br />
Research<br />
Sector Coverage<br />
Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
• Automotive <strong>and</strong> Transportation<br />
• Chemicals & Materials<br />
• Electronics, Semiconductor, <strong>and</strong> ICT • Food <strong>and</strong> Beverages<br />
• Retail <strong>and</strong> Consumer Products<br />
• Services <strong>and</strong> Utilities<br />
• Industrial Automation <strong>and</strong> Equipment • Energy, Mining, Oil, <strong>and</strong><br />
• Healthcare, Pharmaceuticals & Medical Devices Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Liver</strong> transplantation or hepatic transplantation is a surgical procedure performed when the liver<br />
fails to perform its normal functions such as synthesis of carbohydrates, proteins <strong>and</strong> fats. The<br />
liver is the second most commonly transplanted major organ, after the kidney, so it is clear that<br />
liver disease is a common <strong>and</strong> serious problem. Most liver transplant operations use livers from<br />
deceased donors, though a liver may also come from another living person (allograft). There is a<br />
significant proportion of dem<strong>and</strong> liver transplantation currently in dem<strong>and</strong> however, only the<br />
critically ill patients are given the priority <strong>and</strong> selection is based on the criticality of requirement.<br />
There are several disease conditions responsible for liver transplantations such as:<br />
• <strong>Liver</strong> Cirrhosis<br />
• Cystic Fibrosis<br />
• Hemochromatosis<br />
• Primary biliary cirrhosis<br />
• Primary sclerosing cholangitis<br />
• Wilson’s disease<br />
<strong>Liver</strong> transplantation has also been associated with several risk factors such as bleeding, blood<br />
clots, anaphylactic reaction, <strong>and</strong> infection. Other risk factors such as osteopenia, diabetes, high<br />
blood pressure, high cholesterol <strong>and</strong> diarrhea are also observed post transplantation. According<br />
to the American <strong>Liver</strong> Foundation every year more than 1,500 people die waiting for a donated<br />
liver to become available.
Report Description<br />
However, organ transplantation has also been life saving for thous<strong>and</strong>s of people. It has been<br />
studied that almost 6,000 liver transplants are performed annually in the U.S. <strong>and</strong> this number<br />
continues to grow. Currently in the U.S. alone there are almost 17,000 adults <strong>and</strong> children who<br />
have been approved for liver transplantation <strong>and</strong> are awaiting for the donors to make livers<br />
available.<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-<br />
1281<br />
<strong>Liver</strong> <strong>Transplantation</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
<strong>Liver</strong> <strong>Transplantation</strong> market is growing rapidly due to increasing incidence of Hepatitis A, B <strong>and</strong><br />
C across the globe. Major drivers for the liver transplantation market are treatment<br />
advancements, increasing adoption as the most effective modality for the management of endstage<br />
liver disease. Furthermore, increasing favored reimbursement policies is expected to drive<br />
the growth of the liver transplantation market in the near future. However adequate number of<br />
liver donors, increasing waiting list to get a new liver <strong>and</strong> length of hospital stay <strong>and</strong> its cost are<br />
the major factors that can hamper the <strong>Liver</strong> <strong>Transplantation</strong> market growth over the forecast<br />
period.
Report Description<br />
<strong>Liver</strong> <strong>Transplantation</strong> <strong>Market</strong>: Segmentation<br />
The global liver transplantation market is classified on the basis of treatment type, end use <strong>and</strong><br />
geography.<br />
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1281<br />
Based on treatment type, global liver transplantation market is segmented into the following:<br />
• <strong>Liver</strong> <strong>Transplantation</strong> Surgery<br />
• Post-Surgery Anti-Rejection Treatment<br />
• Cyclosporine<br />
• Tacrolimus<br />
• Sirolimus<br />
• Prednisone<br />
• Azathioprine<br />
• Mycophenolate Mofetil<br />
Based on end use, global liver transplantation market is segmented into the following:<br />
• Hospitals<br />
• Adult <strong>Liver</strong> <strong>Transplantation</strong> Centers<br />
• Ambulatory Surgical Centers
Report Description<br />
<strong>Liver</strong> <strong>Transplantation</strong> <strong>Market</strong>: Overview<br />
<strong>Liver</strong> <strong>Transplantation</strong> market is growing with a significant CAGR due to its high adoption rate as<br />
it is an effective modality for the management of end-stage liver disease. Developing countries<br />
are growing with a slower CAGR compared to other parts of the world. By end use, hospitals <strong>and</strong><br />
adult liver transplantation centers segments are expected to account for around 50% share in<br />
the global liver transplantation market <strong>and</strong> the trend is forecast to continue through <strong>2026</strong>.<br />
Based on treatment type, liver transplantation surgery is expected to register above average<br />
CAGR over the forecast period owing surgical techniques <strong>and</strong> innovations in living related liver<br />
transplantations.<br />
<strong>Liver</strong> <strong>Transplantation</strong> <strong>Market</strong>: Region-wise Outlook<br />
Depending on geographic region, global liver transplantation market is segmented into seven<br />
key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific<br />
Excluding Japan, Japan, <strong>and</strong> Middle East & Africa. North America leads the market for liver<br />
transplantation followed by the European countries. Since, the availability of liver donors is<br />
scarce, the market is not yet well established in the developing markets such as India, China <strong>and</strong><br />
others.
Report Description<br />
<strong>Market</strong>: Key Players<br />
Key players in the <strong>Liver</strong> <strong>Transplantation</strong> <strong>Market</strong> include Allosource, Conatus Pharmaceuticals<br />
Inc., Digna Biotech, S.L., Dompe Farmaceutici S.p.A., Isogenis, Inc., RedHill Biopharma Ltd.,<br />
Thompson Surgical, Integra Life sciences <strong>and</strong> others.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact:<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language